Long-term Efficacy and Safety of a Calcineurin Inhibitor-free Regimen in Live-Donor Renal Transplant Recipients

Calcineurin inhibitor (CNI) nephrotoxicity is a major concern after renal transplantation. To investigate the safety and efficacy of a CNI-free immunosuppressive regimen, 132 live-donor renal transplant recipients were included in a prospective, randomized controlled trial. All patients received ind...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American Society of Nephrology Vol. 19; no. 6; pp. 1225 - 1232
Main Authors:	HAMDY, Ahmed F, BAKR, Mohamed A, GHONEIM, Mohamed A
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 01-06-2008 American Society of Nephrology
Subjects:	Adaptor Proteins, Signal Transducing Biological and medical sciences Calcineurin Clinical Research Follow-Up Studies Humans Immunosuppression Therapy - methods Immunosuppressive Agents - therapeutic use Kidney Transplantation Living Donors Medical sciences Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Nephrology. Urinary tract diseases Prospective Studies Sirolimus - therapeutic use Tacrolimus - therapeutic use Time Factors Nephrology Toxicity Calcineurin Living donor Treatment efficiency Free form Transplantation Homotransplantation Long term Kidney Urology Treatment Urinary system Surgery Graft Inhibitor Therapeutic protocol
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!